The deaths are also partly the result of medical successes: People are living longer, and more people are surviving heart ...
Dr. Carlos Rueda, medical director of the St. Mary’s Heart Failure Program, stopped by First Look at Four to tell us about ...
We talk to Dr. Steven Domsky, a heart failure cardiologist with the Lankenau Heart Institute, part of Main Line Health.
Testosterone therapy nearly halves mortality in men with Klinefelter syndrome, highlighting the need for early diagnosis and ...
The University of Rochester continues to work to improve heart failure care, most recently with the launch of two ...
A groundbreaking study shows how Zepbound, a popular weight loss medication, could become a key treatment for heart failure ...
Using the BiovitalsHF software to personalize recommendations got more patients on all four pillars of therapy.
Study led by Mount Sinai researcher shows sotagliflozin is the only drug in its class to demonstrate these results ...
Research Published in the Prestigious Journal of Cardiac Failure From Three InstitutionsOak Ridge, TN, Feb. 13, 2025 (GLOBE NEWSWIRE) -- Daxor ...
Testosterone treatment significantly reduces mortality among men with Klinefelter syndrome. Researcher calls for changes in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results